Filtered By:
Specialty: Cancer & Oncology
Therapy: Palliative
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1660 results found since Jan 2013.
Use of a Person-Centered Narrative Intervention in an Outpatient Palliative Care Setting: A Feasibility Study
J Patient Exp. 2023 Sep 18;10:23743735231202729. doi: 10.1177/23743735231202729. eCollection 2023.ABSTRACTPerson-centered narrative interventions offer potential solutions to facilitate a connection between the person receiving care and the person delivering the care, to improve quality of care, and positively impact a patient's biopsychosocial well-being. This single-arm feasibility study investigates patient-reported outcomes and barriers/facilitators to the implementation of an all-virtually delivered person-centered narrative intervention into the person's electronic health record. Overall, electronic data collection f...
Source: Cancer Control - September 22, 2023 Category: Cancer & Oncology Authors: Heather Coats Nadia Shive C Robert Bennett Bonnie Adrian Andrew D Boyd Ardith Z Doorenbos Sarah J Schmiege Source Type: research
Palliative care in colorectal and anal malignancies from diagnosis to death
This article will review the palliative needs of patients diagnosed with CRC and discuss how PC as a specialty is well poised to support these needs.PMID:37731305 | DOI:10.21037/apm-22-1390
Source: Cancer Control - September 21, 2023 Category: Cancer & Oncology Authors: Mohana Karlekar Khaldoun Almhanna Dana Guyer Source Type: research
Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study
CONCLUSION: For IU-CRLM patients with liver relapse following conversion hepatectomy, the RLDT is essential for cure and prolonged survival. To avoid missing the opportunity for RLDT, intensive disease surveillance should be proposed.PMID:37730473 | DOI:10.1016/j.clcc.2023.08.007
Source: Clinical Colorectal Cancer - September 20, 2023 Category: Cancer & Oncology Authors: Yijiao Chen Dexiang Zhu Miao Chen Yuqiu Xu Qinghai Ye Xiaoying Wang Pingping Xu Qingyang Feng Meiling Ji Ye Wei Jia Fan Jianmin Xu Source Type: research
Clinical outcomes of conversion surgery following immune checkpoint inhibitors and chemotherapy in stage IV gastric cancer
CONCLUSIONS: Conversion surgery holds the potential for significant survival benefits in stage IV GC patients who have achieved a favorable clinical response to immunochemotherapy. Individuals with signet ring cell carcinoma may experience increased post-conversion surgery recurrence.PMID:37720943 | DOI:10.1097/JS9.0000000000000738
Source: Cancer Control - September 18, 2023 Category: Cancer & Oncology Authors: Huayuan Liang Xiao Yan Xinhua Chen Zhiwei Li Yaopeng Qiu Fengping Li Minghao Wang Zhicheng Huang Kaihua Huang Qing Xie Huimin Zhang Guoxin Li Hao Liu Liying Zhao Source Type: research
Integration of palliative care in the management of oral squamous cell carcinoma
Bioinformation. 2023 Jan 31;19(1):1-4. doi: 10.6026/97320630019001. eCollection 2023.ABSTRACTOral Squamous cell Cancers (OSCC) is strongly associated with tobacco consumption. We here in present a case study of a OSCC patient who refused standard oncological care (SOC), to highlight the importance of integrating palliative care (PC) for improved patient outcomes. A 61 years male patient, with history of chewing tobacco for more than 20 years and diagnosed to have OSCC for 1.5 years presented with severe anaemia and a cauliflower-like growth (12 x 10 cm) in the left oral cavity and cheek with greenish-yellow discharge. Pus ...
Source: Cancer Control - September 18, 2023 Category: Cancer & Oncology Authors: Republica Sridhar Huwait Etimad Peter Natesan Pushparaj Gauthaman Kalamegam Source Type: research
Recommendations on palliative care aspects in intensive care medicine
CONCLUSION: The timely integration of palliative care into intensive care medicine aims to improve quality of life and symptom control and also takes into acccount the often urgently needed support for patients' highly stressed relatives.PMID:37723595 | DOI:10.1186/s13054-023-04622-3
Source: Cancer Control - September 18, 2023 Category: Cancer & Oncology Authors: Guido Michels Manuela Schallenburger Martin Neukirchen ICU Palliative Study Group Source Type: research
Dissemination and Implementation of a Community Health Worker Intervention for Disparities in Palliative Care (DeCIDE PC): a study protocol for a hybrid type 1 randomized controlled trial
DISCUSSION: We expect the DeCIDE PC intervention to improve integration of palliative care, reduce multilevel barriers to care, enhance clinic and patient linkage to resources, and ultimately improve palliative care outcomes for African American patients with advanced cancer. If found to be effective, the DeCIDE PC intervention may be a transformative model with the potential to guide large-scale adoption of promising strategies to improve palliative care use and decrease disparities in end-of-life care for African American patients with advanced cancer in the United States.TRIAL REGISTRATION: Registered on ClinicalTrials....
Source: Cancer Control - September 17, 2023 Category: Cancer & Oncology Authors: Amn Siddiqi Olivia Monton Alison Woods Taleaa Masroor Shannon Fuller Jill Owczarzak Gayane Yenokyan Lisa A Cooper Karen M Freund Thomas J Smith Jean S Kutner Kathryn L Colborn Robert Joyner Ronit Elk Fabian M Johnston Source Type: research
Survival outcome in early onset metastatic colorectal cancer: a multicenter matched-pair analysis
Conclusion Our study suggests that younger patients benefit at least to the same magnitude or even more from mCRC-treatment than patients aged 50 or above.PMID:37699362 | DOI:10.1159/000533429
Source: Cancer Control - September 12, 2023 Category: Cancer & Oncology Authors: Bernhard Doleschal Dora Nieders üß-Beke Patrick Kirchweger Andreas Petzer Josef Thaler Holger Rumpold Source Type: research
Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark
CONCLUSION: Stage III NSCLC is a heterogeneous disease as regards patient and clinical characteristics, multiple treatment options, and outcomes. Age, disease staging, performance status, and comorbidity, as well as MDT evaluation and matching treatment intent, are important determinants of curative-intended treatment. Notably, an NSCLC diagnosis in the more contemporary study period was statistically significantly associated with better OS.PMID:37699061 | DOI:10.1080/0284186X.2023.2254474
Source: Acta Oncologica - September 12, 2023 Category: Cancer & Oncology Authors: Peter Meldgaard Michael Kristensen Simona Conte Klaus Kaae Andersen Aleksander Jovanovic Ebbe Meldgaard Source Type: research
Continuous Tunneled Infraclavicular Nerve Catheter for Palliative Management of Critical Limb Ischemia: A Case Report
We describe the successful use of a continuous local anesthetic infusion via an infraclavicular nerve catheter to control severe refractory ischemic upper limb pain in a patient with metastatic lung cancer for whom surgical and pharmacological intervention was unsuccessful. As her opioid requirements increased due to worsening ischemic pain, she subsequently developed opioid toxicity, hence prompting the palliative use of a tunneled infraclavicular nerve catheter under ultrasound guidance to minimize opioid requirements. Her opioid requirements tailed down subsequently with the successful insertion of the infraclavicular n...
Source: Cancer Control - September 12, 2023 Category: Cancer & Oncology Authors: Jia Lin Jacklyn Yek Nicodemus Oey Amit Jain Christopher Liu Nithia Angamuthu Source Type: research
Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark
CONCLUSION: Stage III NSCLC is a heterogeneous disease as regards patient and clinical characteristics, multiple treatment options, and outcomes. Age, disease staging, performance status, and comorbidity, as well as MDT evaluation and matching treatment intent, are important determinants of curative-intended treatment. Notably, an NSCLC diagnosis in the more contemporary study period was statistically significantly associated with better OS.PMID:37699061 | DOI:10.1080/0284186X.2023.2254474
Source: Acta Oncologica - September 12, 2023 Category: Cancer & Oncology Authors: Peter Meldgaard Michael Kristensen Simona Conte Klaus Kaae Andersen Aleksander Jovanovic Ebbe Meldgaard Source Type: research
Survival outcome in early onset metastatic colorectal cancer: a multicenter matched-pair analysis
Conclusion Our study suggests that younger patients benefit at least to the same magnitude or even more from mCRC-treatment than patients aged 50 or above.PMID:37699362 | DOI:10.1159/000533429
Source: Oncology - September 12, 2023 Category: Cancer & Oncology Authors: Bernhard Doleschal Dora Nieders üß-Beke Patrick Kirchweger Andreas Petzer Josef Thaler Holger Rumpold Source Type: research
Outcomes of Patients With Colorectal Liver Metastasis in the Developing World: Is Liver Transplantation for Unresectable Liver Metastasis, the Next Logical Step?
CONCLUSION: Liver transplant has the potential to benefit a small but significant portion of patients with unresectable liver metastasis.PMID:37693265 | PMC:PMC10483002 | DOI:10.1016/j.jceh.2023.03.009
Source: Clinical Colorectal Cancer - September 11, 2023 Category: Cancer & Oncology Authors: Janesh M Mufaddal Kazi Shraddha Patkar Prudvi Raj S Abhiram Bhoyar Ashwin Desouza Avanish Saklani Mahesh Goel Source Type: research
